Loan & DebtJun 17, 2026, 08:06 AM
Gossamer Bio Finalizes Exchange Offer; $18.9M Notes Remain
AI Summary
Gossamer Bio, Inc. announced the final tender results for its exchange offer of 5.00% Convertible Senior Notes due 2027. The company successfully exchanged $181,052,000 of the existing notes for new 7.50% Convertible Senior Secured First Lien Notes due 2030, common stock, and warrants, after amending the minimum tender condition to 90.5%. Following the offer, $18,948,000 in existing notes will remain outstanding. Stockholder proposals related to the exchange offer will be voted on at a special meeting on July 14, 2026.
Key Highlights
- Gossamer Bio finalized its exchange offer for 5.00% Convertible Senior Notes due 2027.
- $181,052,000 in Existing Convertible Notes were tendered by June 2, 2026.
- The minimum tender condition was reduced from 98% to 90.5% of notes.
- New 7.50% Convertible Senior Secured First Lien Notes due 2030 were issued.
- Up to 317,647,058 shares of common stock or prefunded warrants were issued.
- $18,948,000 in Existing Convertible Notes will remain outstanding.
- A special stockholder meeting is set for July 14, 2026, for related proposals.
Price Impact
More from GOSS